Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Hematological Malignancy (Leukemia- Lymphoma)

Mansoura UniversitySmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Hematological Malignancy (Leukemia- Lymphoma) cohort.

Asset / SponsorPhaseRating
FENTANYL
City of Hope Medical Center
Phase 4BBB
Ketorolac Tromethamine
City of Hope Medical Center
Phase 4BB
gt719
Grit Biotechnology
Phase 1/2CCC

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →